… ,17], and pediatric patients tend to be de novo [13]. There are … clinical features that mimic
acute promyelocytic leukemia (… often show unique clinical and biological characteristics [22]. …

… La t(8;16)(p11;p13) est rare au cours de cette pathologie. Nous décrivons le cas d'une
patiente de 22 ans, admise pour un syndrome d'insuffisance médullaire complet associé à une …

… Collaboration has evolved to encompass different … The t(8;16)(p11;p13) translocation may
have an age-dependent … The BFM-AML Study Group currently employs a high dose of DNX (…

… (AML) is a rare subgroup of AML of pediatric patients under … in AML associated with t(8;16)(p11;p13)
[15,16]. These … Some collaborative groups have defined AML<1 year old as a …

… CBF AML study [89], confirming the previous results in inv(16) … a relatively biological and
clinical homogeneous group with a … The translocation t(8;16)(p11;p13) is a rare entity leading to …

… child with congenital acute myeloid leukemia (AML) with t(8 ; … ; p13) are a distinct clinical
and biological entity. For example… the Japanese Childhood AML Cooperative Study Group. J …

… acute myeloid leukemia. It has also been reported in patients with … at(8;16)(p11.2;p13.3)
has distinctive morphologic and clinical features … /Eastern Cooperative Oncology Group study …

… clinical trials in the field of pediatric hemato-oncology since 1972. For … can also occur in
neonates with t(8;16)(p11;p13) [28]. Future … Collaborations with international study groups remain …

… Decades of coordinated efforts through cooperative group … with unique clinical
characteristics such as leukemia cutis, … The fusion of ETV6 with MNX1, resulting from t(7;12)(q36;p13), …

… different systems exist for subclassification of acute myeloid … 2 Studies on clinical
characteristics and outcome in pediatric … A total of 159 cases of AML carrying the t(8;16)(p11;p13) …